Literature DB >> 21187117

Detection of chimpanzee polyomavirus-specific antibodies in captive and wild-caught chimpanzees using yeast-expressed virus-like particles.

Anja Zielonka1, Ernst J Verschoor, Alma Gedvilaite, Uwe Roesler, Hermann Müller, Reimar Johne.   

Abstract

Chimpanzee polyomavirus (ChPyV) was originally detected in the faeces of a captive chimpanzee by random screening using broad-spectrum PCR. Its pathogenicity and the distribution among chimpanzees are unknown so far. Here, the major capsid protein VP1 of ChPyV was expressed in yeast cells. Virus-like particles (VLPs) with a diameter of approximately 45nm were demonstrated although the efficiency of VLP formation was low as compared to monkey polyomavirus SV40-VLPs. The ChPyV-VLP preparation did not agglutinate human erythrocytes. Low cross-reactions between ChPyV- and SV40-VLP-specific sera were detected by immunoblotting, but not by ELISA. Testing of 163 sera derived from captive and wild-caught healthy chimpanzees using an ELISA based on the ChPyV-VLPs resulted in 11.7% positive results, ranging from 0% to 56% in different groups. The VLPs may be used in future to assess the distribution of ChPyV infections among other animal species and humans. Copyright Â
© 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21187117     DOI: 10.1016/j.virusres.2010.12.009

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  2 in total

1.  Role of the C-terminal region of vervet monkey polyomavirus 1 VP1 in virion formation.

Authors:  Hiroki Yamaguchi; Shintaro Kobayashi; Junki Maruyama; Michihito Sasaki; Ayato Takada; Takashi Kimura; Hirofumi Sawa; Yasuko Orba
Journal:  J Vet Med Sci       Date:  2014-01-13       Impact factor: 1.267

2.  Serological cross-reactivity between Merkel cell polyomavirus and two closely related chimpanzee polyomaviruses.

Authors:  Jérôme T J Nicol; Etienne Liais; Romain Potier; Elisa Mazzoni; Mauro Tognon; Pierre Coursaget; Antoine Touzé
Journal:  PLoS One       Date:  2014-05-09       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.